A novel missense variant in the RASGRP2 gene in patients with moderate to severe bleeding disorder

References

• Nurden A, Nurden P. Advances in our understanding of the molecular basis of disorders of platelet function. J Thromb Haemost 2011;1:76–91. doi: 10.1089/ars.2016.6904.
   Google Scholar
• Sevivas T, Bastida JM, Paul DS, Caparros E, Palma-Barqueros V, Coucelo M, Marques D, Ferrer-Marín F, González-Porras JR, Vicente V, et al. Identification of two novel mutations in RASGRP2 affecting platelet CalDAG-GEFI expression and function in patients with bleeding diathesis. Platelets 2018;29:192–195. doi: 10.1080/09537104.2017.
   PubMed Web of Science ®Google Scholar
• Nurden AT, Caen JP. An abnormal platelet glycoprotein pattern in three cases of Glanzmann’s thrombasthenia. Br J Haematol 1974;28:253–260. doi: 10.1111/j.1365-2141.1974.tb06660.x.
   PubMed Web of Science ®Google Scholar
• Stevens RF, Meyer S. Fanconi and Glanzmann: the men and their works. Br J Haematol 2002;119:901–904. doi: 10.1046/j.1365-2141.2002.03812.x.
   PubMed Web of Science ®Google Scholar
• Coller BS, Shattil SJ. The GPIIb/IIIa (integrin αIIbβ3) odyssey: a technology-driven saga of a receptor with twists, turns, and even a bend. Blood 2008;112:3011–3325. doi: 10.1182/blood-2008-06-077891.
   PubMed Web of Science ®Google Scholar
• Shattil SJ, Kim C, Ginsberg MH. The final steps of integrin activation: the end game. Nat Rev Mol Cell Biol 2010;11:288–300. doi: 10.1038/nrm2871.
   PubMed Web of Science ®Google Scholar
• Buyukasik Y, Karakus S, Goker H, Haznedaroglu IC, Ozatli D, Sayinalp N, Ozcebe OI, Dundar SV, Kirazli S. Rational use of the PFA-100 device for screening of platelet function disorders and von Willebrand disease. Blood Coagul Fibrinolysis 2002;13:349–353.
   PubMed Web of Science ®Google Scholar
• Bellucci S, Caen J. Molecular basis of Glanzmann’s thrombasthenia and current strategies in treatment. Blood Rev 2002;16:193–202. doi: 10.1016/S0268-960X(02)00030-9.
   PubMed Web of Science ®Google Scholar
• Nurden AT, Fiore M, Nurden P, Pillois X. Glanzmann thrombasthenia: a review of ITGA2B and ITGB3 defects with emphasis on variants, phenotypic variability, and mouse models. Blood 2011;118:5996–6005. doi: 10.1182/blood-2011-07-365635.
   PubMed Web of Science ®Google Scholar
• D’Andrea G, Colaizzo D, Vecchione G, Grandone E, Di Minno G, Margaglione M. Glanzmann’s thrombasthenia: identification of 19 new mutations in 30 patients. Thromb Haemost 2002;87:1034–1042.
   PubMed Web of Science ®Google Scholar
• Nurden P, Bordet JC, Pillois X, Nurden AT. An intracytoplasmic b3 Leu718 deletion in a patient with a novel platelet phenotype. Blood Adv 2017;1:494–499. doi: 10.1182/bloodadvances.2016002808.
   PubMed Web of Science ®Google Scholar
• Yun JW, Lee KO, Jung CW, Oh SY, Kim SH, Choi CW, Kim HJ. Hereditary platelet function disorder from RASGRP2 gene mutations encoding CalDAG-GEFI identified by whole exome sequencing in a Korean woman with severe bleeding. Haematologica 2019;104:e274–e276. pii: haematol.2019.218487. doi: 10.3324/haematol.2019.218487.
   PubMed Web of Science ®Google Scholar
• Muller WA. Identification of a severe bleeding disorder in humans caused by a mutation in CalDAG-GEFI. J Exp Med 2014;211:1271. doi: 10.1084/jem.2117insight1.
   PubMedGoogle Scholar
• Canault M, Ghalloussi D, Grosdidier C, Guinier M, Perret C, Chelghoum N, Germain M, Raslova H, Peiretti F, Morange PE et al. Human CalDAG-GEFI gene (RASGRP2) mutation affects platelet function and causes severe bleeding. J Exp Med. 2014;211:1349-1362. doi: 10.1084/jem.20130477.
   Google Scholar
• Desai A, Bergmeier W, Canault M, Alessi MC, Paul DS, Nurden P, Pillois X, Jy W, Ahn YS, Nurden AT. Phenotype analysis and clinical management in a large family with a novel truncating mutation in RASGRP2, the CalDAG-GEFI encoding gene. Res Pract Thromb Haemost 2017;1:128–133. doi: 10.1002/rth2.12019.
   PubMed Web of Science ®Google Scholar
• Lozano ML, Cook A, Bastida JM, Paul DS, Iruin G, Cid AR, Adan-Pedroso R, Ramón González-Porras J, Hernández-Rivas JM, Fletcher SJ, et al. Novel mutations in RASGRP2, which encodes CalDAG-GEFI, abrogate Rap1 activation, causing platelet dysfunction. Blood 2016 Sep 1;128:1282–1289. doi: 10.1182/blood-2015-11-683102.
   PubMed Web of Science ®Google Scholar
• Palma-Barqueros V, Ruiz-Pividal J, Bohdan N, Vicente V, Bastida JM, Lozano M, Rivera J. RASGRP2 gene variations associated with platelet dysfunction and bleeding. Platelets 2019;30:535–539. doi: 10.1080/09537104.2019.1585528.
   PubMed Web of Science ®Google Scholar
• Leo VC, Morgan NV, Bem D, Jones ML, Lowe GC, Lordkipanidzé M, Drake S, Simpson MA, Gissen P, Mumford A, et al. Use of next-generation sequencing and candidate gene analysis to identify underlying defects in patients with inherited platelet function disorders. J Thromb Haemost 2015;13:643–650. doi: 10.1111/jth.12836.
   PubMed Web of Science ®Google Scholar
• Laffan M. BRIDGE bleeding and platelet disorders consortium. A whole genome approach to platelet and bleeding disorders. Hamostaseologie 2016;36:161–166. doi: 10.5482/HAMO-14-11-0056.
   PubMed Web of Science ®Google Scholar
• Maclachlan A, Watson SP, Morgan NV. Inherited platelet disorders: insight from platelet genomics using next-generation sequencing. Platelets 2017;28:14–19. doi: 10.1080/09537104.2016.1195492.
   PubMed Web of Science ®Google Scholar
• Hashmi JA, Safar RA, Afzal S, Albalawi AM, Abdu-Samad F, Iqbal Z, Basit S. Whole exome sequencing identification of a novel insertion mutation in the phospholipase C ε‑1 gene in a family with steroid resistant inherited nephrotic syndrome. Mol Med Rep 2018;18:5095–5100. doi: 10.3892/mmr.2018.9528.
   PubMed Web of Science ®Google Scholar
• Alharbi KM, Al-Mazroea AH, Abdallah AM, Almohammadi Y, Carlus SJ, Basit S. Targeted next-generation sequencing of 406 genes identified genetic defects underlying congenital heart disease in down syndrome patients. Pediatr Cardiol 2018;39:1676–1680. doi: 10.1007/s00246-018-1951-3.
   PubMed Web of Science ®Google Scholar
• Khan MJ, Nazli R, Ahmed J, Basit S. Whole genome sequencing instead of whole exome sequencing is required to identify the genetic causes of polycystic ovary syndrome in Pakistani families. Pak J Med Sci 2018;34:540–545. doi: 10.12669/pjms.343.14644.
   PubMed Web of Science ®Google Scholar
• Hashmi JA, Almatrafi A, Latif M, Nasir A, Basit S. An 18 bps in-frame deletion mutation in RUNX2 gene is a population polymorphism rather than a pathogenic variant. Eur J Med Genet 2019;62:124–128. doi: 10.1016/j.ejmg.2018.06.013.
   PubMed Web of Science ®Google Scholar
• Yang J, Yan R, Roy A, Xu D, Poisson J, Zhang Y. The I-TASSER Suite: protein structure and function prediction. Nat Methods 2015;12:7–8. doi: 10.1038/nmeth.3213.
   PubMed Web of Science ®Google Scholar
• Reif MM, Hünenberger PH, Oostenbrink C. New interaction parameters for charged amino acid side chains in the GROMOS force field. J Chem Theory Comput 2012;8:3705–3723. doi: 10.1021/ct300156h.
   PubMed Web of Science ®Google Scholar
• Basit S, Al-Harbi KM, Alhijji SA, Albalawi AM, Alharby E, Eldardear A, Samman MI. CIT, a gene involved in neurogenic cytokinesis, is mutated in human primary microcephaly. Hum Genet 2016;135:1199–1207. doi: 10.1007/s00439-016-1724-0.
   PubMed Web of Science ®Google Scholar
• Savojardo C, Fariselli P, Martelli PL, Casadio R. INPS-MD: a web server to predict stability of protein variants from sequence and structure. Bioinformatics 2016;32:2542–2544. doi: 10.1093/bioinformatics/btw192.
   PubMed Web of Science ®Google Scholar
• Ross DW, Ayscue LH, Watson J, Bentley SA. Stability of hematologic parameters in healthy subjects. Intraindividual versus interindividual variation. Am J Clin Pathol 1988;90:262–267. doi: 10.1093/ajcp/90.3.262.
   PubMed Web of Science ®Google Scholar
• Watson SP, Lowe GC, Lordkipanidze M, Morgan NV. Genotyping and phenotyping of platelet function disorders. J Thromb Haemost 2013;11:351–363. doi: 10.1111/bjh.14796.
   PubMed Web of Science ®Google Scholar
• Bolton-Maggs PH, Chalmers EA, Collins PW, Harrison P, Kitchen S, Liesner RJ, Minford A, Mumford AD, Parapia LA, Perry DJ, et al. A review of inherited platelet disorders with guidelines for their management on behalf of the UKHCDO. Br J Haematol 2006;135:603–633. doi: 10.1111/j.1365-2141.2006.06343.x.
   PubMed Web of Science ®Google Scholar
• Boettner B, Van Aelst L. Control of cell adhesion dynamics by Rap1 signaling. Curr Opin Cell Biol 2009;21:684–693. doi: 10.1016/j.ceb.2009.06.004.
   PubMed Web of Science ®Google Scholar
• Ebinu JO, Bottorff DA, Chan EY, Stang SL, Dunn RJ, Stone JC. RasGRP, a Ras guanyl nucleotide-releasing protein with calcium-and diacylglycerol-binding motifs. Science 1998;280:1082–1086. doi: 10.1126/science.280.5366.1082.
   PubMed Web of Science ®Google Scholar
• Chrzanowska-Wodnicka M. Distinct functions for Rap1 signaling in vascular morphogenesis and dysfunction. Exp Cell Res 2013;319:2350–2359. doi: 10.1016/j.yexcr.2013.07.022.
   PubMed Web of Science ®Google Scholar
• Westbury SK, Canault M, Greene D, Bermejo E, Hanlon K, Lambert MP, Millar CM, Nurden P, Obaji SG, Revel-Vilk S, et al. Expanded repertoire of RASGRP2 variants responsible for platelet dysfunction and severe bleeding. Blood 2017;130:1026–1030. doi: 10.1182/blood-2017-03-776773.
   PubMed Web of Science ®Google Scholar
• Bermejo E, Alberto MF, Paul DS, Cook AA, Nurden P, Sanchez Luceros A, Nurden AT, Bergmeier W. Marked bleeding diathesis in patients with platelet dysfunction due to a novel mutation in RASGRP2, encoding CalDAG-GEFI (p.Gly305Asp). Platelets 2018;29:84–86. doi: 10.1080/09537104.2017.1332759.
   PubMed Web of Science ®Google Scholar